FDA could approve ketamine nasal spray as depression treatment

New York — The FDA may be on the verge of approving the first new treatment for depression in decades. One out of every six adults will have depression at some point in their life, and it affects about 16 million Americans every year. Michael Wurst, 37, is a newlywed with a new home and a life far different than it was just a few years ago. "You don't feel anything positive. It was a struggle, an absolute struggle," Wurst said. Anti-depressants didn't help enough. Then in a 2017 clinical trial, Wurst was given six weekly infusions of ketamine, a rapid acting anesthetic that's been used illegally as a party drug known as "Special K." By the fourth treatment he was a changed man. "It ... | Read more at cbsnews.com